Quality of evidence on pre-eclampsia in the last three decades: An analysis of published literature
ConclusionThe yearly number of publications on pre-eclampsia has substantially increased, with a stable number of high-level study types and publications from high-impact journals. The reporting quality and usefulness of RCTs relating to pre-eclampsia have improved over time.
Publication date: Available online 21 September 2020Source: Pregnancy HypertensionAuthor(s): Kim J.C. Verschueren, Rubinah R. Paidin, Annabel Broekhuis, Olivier S.S. Ramkhelawan, Lachmi R. Kodan, Humphrey H.H. Kanhai, Joyce L. Browne, Kitty W.M. Bloemenkamp, Marcus J. Rijken
Publication date: Available online 17 September 2020Source: Pregnancy HypertensionAuthor(s): Anne Karge, Lina Beckert, Philipp Moog, Bernhard Haller, Javier U. Ortiz, Silvia M. Lobmaier, Kathrin Abel, Sarah Flechsenhar, Bettina Kuschel, Oliver Graupner
CONCLUSIONS: Maternal pre-eclampsia, but not gestational hypertension, was associated with persistently elevated trajectory of offspring emotional and behavioural problems. Our findings highlight that the antenatal environment is important for children's behavioural and emotional development. PMID: 32950656 [PubMed - as supplied by publisher]
This study was a clinical trial performed on 339 women with singleton pregnancy aged 18-35 and gestational age of 20 weeks who visited prenatal clinic at Kosar Hospital in Qazvin during 2015-2016. Patients were randomly divided into two groups marked as intervention group which received soft gelatin capsules (each containing 1000 mg fish oil including 120 mg DHA and 180 mg EPA) on a daily basis from the 20th week to the end of pregnancy, and the women in the control group with no fish oil intake. The outcomes of pregnancy including preeclampsia, eclampsia, preterm labor, gestational diabetes, weight, height, head circumfer...
CONCLUSIONS: PE-related placental/extraplacental membrane findings help risk stratify women with moderately-elevated BP in pregnancy for later development of hypertension. PMID: 32931608 [PubMed - as supplied by publisher]
ConclusionIn our study, not only did the rates of different risk factors for pre-eclampsia change over the study period, the specific contribution of each risk factor for the occurrence of pre-eclampsia changed as well. Developing a better understanding of these trends might aid in our ability to predict this major complication and to improve maternal and fetal outcomes.
WHO recommendations on drug treatment for non-severe hypertension in pregnancyCochrane has been a non-governmental organization in official relations with the World Health Organization (WHO) since 2011. WHO develops global health guidelines, which are of a high methodological quality and are developed through a transparent, evidence-based decision-making process. Ensuring there is an appropriate use of evidence within these guidelines, represents one of thecore functions of WHO.WHO has recently released recommendations on drug treatment for non-severe hypertension in pregnancy. The primary audience of this reco...
Conditions: Gestational Hypertension; Pre-eclampsia Interventions: Procedure: Laser Doppler coupled with acetylcholine iontophoresis; Procedure: Aortic central pressure and the carotid-femoral pulse wave velocity; Other: Vascular biomarker assay Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting
Women who experience vascular complications of pregnancy, including pre-eclampsia, hypertension and diabetes, are at increased risk of coronary artery disease (CAD). Yet patients and their medical providers have low awareness of the significance of these ‘non-traditional’ cardiovascular risk factors. We aimed to determine the prevalence and medical provider awareness of pregnancy-related cardiovascular risk factors in women with CAD.